Search Results

Judgment of the General Court (First Chamber, Extended Composition) of 20 December 2023.
Ekaterina Islentyeva v Council of the European Union.
Action for annulment – Common foreign and security policy – Restrictive measures adopted in view of Russia’s actions destabilising the situation in Ukraine – Prohibition on any non-Russian-registered aircraft owned, chartered or otherwise controlled by any Russian natural or legal person, entity or body, from landing in, taking off from, or overflying the territory of the European Union – Article 4e of Decision 2014/512/CFSP – Lack of jurisdiction of the General Court – Article 3d of Regulation (EU) No 833/2014 – Lack of locus standi – Inadmissibility.
Case T-233/22.

Court reports – general – 'Information on unpublished decisions' section

ECLI identifier: ECLI:EU:T:2023:828

Judgment of the Court (Second Chamber) of 13 October 2022.
M2Beauté Cosmetics GmbH v Bundesrepublik Deutschland.
Request for a preliminary ruling from the Verwaltungsgericht Köln.
Reference for a preliminary ruling – Medicinal products for human use – Directive 2001/83/EC – Article 1(2)(b) – Concept of ‘medicinal product by function’ – No scientific study – Scientific knowledge on a structural analogue – Regulation (EC) No 1223/2009 – Cosmetic product – Specific beneficial effects on human health – Direct or indirect beneficial effects – Positive effects on appearance.
Case C-616/20.

ECLI identifier: ECLI:EU:C:2022:781

Opinion of Advocate General Ćapeta delivered on 7 April 2022.
M2Beauté Cosmetics GmbH v Bundesrepublik Deutschland.
Request for a preliminary ruling from the Verwaltungsgericht Köln.
Reference for a preliminary ruling – Medicinal products for human use – Directive 2001/83/EC – Article 1(2)(b) – Concept of ‘medicinal product by function’ – No scientific study – Scientific knowledge on a structural analogue – Regulation (EC) No 1223/2009 – Cosmetic product – Specific beneficial effects on human health – Direct or indirect beneficial effects – Positive effects on appearance.
Case C-616/20.

ECLI identifier: ECLI:EU:C:2022:284

Judgment of the General Court (Seventh Chamber, Extended Composition) of 5 May 2021.
Pharmaceutical Works Polpharma S.A. v European Medicines Agency.
Medicinal products for human use – Application for marketing authorisation for a generic version of the medicinal product Tecfidera – Decision of the EMA not to validate the application for marketing authorisation – Previous decision of the Commission taking the view that Tecfidera – Dimethyl fumarate was not covered by the same global marketing authorisation as Fumaderm – Plea of illegality – Admissibility – Previously authorised combination medicinal product – Subsequent marketing authorisation for a component of the combination medicinal product – Assessment of the existence of two different global marketing authorisations – Manifest error of assessment.
Case T-611/18.

Court reports – general

ECLI identifier: ECLI:EU:T:2021:241

Opinion of Advocate General Campos Sánchez-Bordona delivered on 9 July 2020.
A.M. v E.M.
Request for a preliminary ruling from the Sąd Okręgowy w Warszawie.
Reference for a preliminary ruling – Approximation of laws – Cosmetic products – Regulation (EC) No 1223/2009 – Article 19 – Consumer information – Labelling – Information that must appear on the product container and packaging – Labelling in a foreign language – ‘Function of the cosmetic product’ – Concept – Cosmetic product packaging which contains a reference to a detailed product catalogue drafted in the language of the consumer.
Case C-667/19.

ECLI identifier: ECLI:EU:C:2020:554

Judgment of the General Court (Seventh Chamber) of 22 March 2018.
Shire Pharmaceuticals Ireland Ltd v European Medicines Agency.
Medicinal products for human use — Validation of an application for designation as an orphan medicinal product — Significant benefit — EMA decision refusing to validate an application for designation as an orphan medicinal product — Article 3(1)(b) and Article 5(1), (2) and (4) of Regulation (EC) No 141/2000.
Case T-80/16.

ECLI identifier: ECLI:EU:T:2018:165

Judgment of the Court (First Chamber) of 21 September 2016.
European Federation for Cosmetic Ingredients v Secretary of State for Business, Innovation and Skills and Attorney General.
Request for a preliminary ruling from the High Court of Justice (England & Wales), Queen's Bench Division (Administrative Court).
Reference for a preliminary ruling — Approximation of laws — Cosmetic products — Regulation (EC) No 1223/2009 — Article 18(1)(b) — Cosmetic products containing ingredients, or a combination of ingredients, which have been the subject of animal testing ‘in order to meet the requirements of this Regulation’ — Prohibition of marketing within the European Union — Scope.
Case C-592/14.

Court reports – general

ECLI identifier: ECLI:EU:C:2016:703

Judgment of the Court (Fifth Chamber) of 12 February 2015.
N.F. Gielen and Others.
Request for a preliminary ruling from the Rechtbank Oost-Brabant ’s-Hertogenbosch.
Reference for a preliminary ruling — Drug precursors — Monitoring of trade between the Member States — Regulation (EC) No 273/2004 — Monitoring of trade between the European Union and third countries — Regulation (EC) No 111/2005 — Concept of ‘scheduled substance’ — Substance ‘alpha-phenylacetoacetonitrile’ (APAAN) — Scheduled substance ‘1-phenyl-2-propanone’ (BMK).
Case C-369/13.

Court reports – general

ECLI identifier: ECLI:EU:C:2015:85

Joined Cases C-358/13 and C 181/14: Judgment of the Court (Fourth Chamber) of 10 July 2014 (requests for a preliminary ruling from the Bundesgerichtshof — Germany) — Criminal proceedings against Markus D. (C 358/13) and G. (C-181/14) ((Medicinal products for human use — Directive 2001/83/EC — Scope — Interpretation of the concept of ‘medicinal product’  — Scope of the criterion based on the capacity to modify physiological functions — Herb and cannabinoid-based products — Not included)

OJ C 315, 15/09/2014, p. 19–19 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ C 315, 15/09/2014, p. 19–19